# Perineural Injections of Incobotulinumtoxin-A for Diabetic Neuropathic Pain of the Lower Extremities

> **NCT05623111** · PHASE2 · RECRUITING · sponsor: **Rigshospitalet, Denmark** · enrollment: 80 (estimated)

## Conditions studied

- Diabetic Neuropathy, Painful

## Interventions

- **DRUG:** Incobotulinumtoxin-A 100 UNIT Injection
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT05623111
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-01
- **Primary completion:** 2027-05-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-12-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05623111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05623111, "Perineural Injections of Incobotulinumtoxin-A for Diabetic Neuropathic Pain of the Lower Extremities". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05623111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*